Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy
Journal of Nephrology, 06/29/09
Bazzi C et al. - Renoprotection by ACEi is a multifactorial phenomenon: the best predictor of renoprotection is FEIgG, a marker of disruption of glomerular barrier to proteins; renoprotection depends not only on ability to reduce proteinuria, but probably also on antiinflammatory and antifibrotic activity.
Related Articles
Renal Cell Carcinoma in Association With IgA Nephropathy in the Elderly
The American Journal of the Medical Sciences, 11/13/09
Relevance Score: 69%
Intrarenal expression of microRNAs in patients with IgA nephropathy
Laboratory Investigation, 11/12/09
Relevance Score: 69%
Parallel Genotyping of 10,204 Single Nucleotide Polymorphisms to Screen for Susceptible Genes for IgA Nephropathy
Annals, Academy of Medicine, Singapore, 11/03/09
Relevance Score: 66%
Leptospirosis and Goodpastures syndrome: testing the aetiological hypothesis
Annals of Tropical Medicine and Parasitology, 11/02/09
Relevance Score: 64%
Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity
Platelets, 10/30/09
Relevance Score: 46%
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Waging War against Uropathogenic Escherichia coli: Winning Back the Urinary Tract
Infection and Immunity, 11/25/09
Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
Transplantation Proceedings, 11/23/09
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


